Complex Generic Sponsors Not Using US FDA-EMA Parallel Scientific Advice Program

 
• By Derrick Gingery
  
US and EU collaboration
FDA officials believe the FDA-EMA parallel scientific advice program could be beneficial for complex generic sponsors. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics